Market Research Future (MRFR) speculates that the global superdisintegrants systems market
is slated to garner USD 576.2 million, grabbing a CAGR of 7.9% during the forecast period (2018
to 2023). Increased production of generic drugs is predicted to is estimated to favor the market
growth in the coming years. Disintegrants are referred to as substances which are generally
included in drug formula in order to allow proper disintegration of the tablet or capsule into
dissolvable particles. Superdisintegrants are added to drug formulation to facilitate the
dissolution of the capsule content into reduced particles. Crospovidone, sodium starch
glycolate, and croscarmellose sodium are some of the widely used products.
Market Potential and Pitfalls
Request Sample Copy:
The pharmaceutical sector is observed to grow at a breakneck and is becoming an important
part of the healthcare sector owing to the increasing population of both pediatric as well as
geriatric patients. Superdisintegrants help to treat patients of this demographic as these tablets
can be swallowed easily. With the growth of the demographic, the market for
Superdisintegrants is estimated to flourish. Generic drugs are also high in demand as patents
are running out on popular drug brands, thereby opening up the pharmaceutical sector for
rising entry of competition and increased manufacturing of generic drugs. This has further
propelled the market demand for superdisintegrants across the globe.
On the contrary, lack of investment in research and development activities is predicted to deter
the superdisintegrants systems market throughout the appraisal period.
Global Superdisintegrants Systems Market: Segmental Analysis
The global superdisintegrants systems market has been segmented on the basis of formulation,
type, and therapeutic area.
By mode of type, the global superdisintegrants systems market has been segmented into
natural disintegrants, synthe